Advancing PDE4 Inhibition Beyond IBD: Implications for PDE4 Inhibition & Pleiotropic Mechanisms in Systemic Sclerosis
2:00 pm - Wednesday 2nd December 2026
- Examining the epithelial-fibroblast mechanistic interplay underlying PDE4 inhibitor efficacy in lung, skin, & gut fibrosis
- Assessing the translational pathway from preclinical models to clinical development & understanding efficacy benchmarks
- Identifying opportunities for pleiotropic anti-inflammatory & antifibrotic mechanisms in other progressive fibrosing diseases
